Two More Compounders Warned for Poor Sterile Drug Manufacturing

Compounding pharmacies continue to be plagued by sterility issues, as the FDA handed warning letters to facilities in Florida and Kentucky — bringing to nine the number of compounders cited for such deficiencies since October.

Source:: Drug Industry Daily

Leave a Reply

Your email address will not be published. Required fields are marked *